Jurny Selects RAD AI for Creative Intelligence and Influencer Marketing
LOS ANGELES–(BUSINESS WIRE)–#ContentAI–Rad Technologies, Inc., doing business as Rad Intelligence, an artificial intelligence company that…
Month: January 2023
Zeta to Announce Fourth Quarter 2022 Results on February 23, 2023
NEW YORK–(BUSINESS WIRE)–Zeta Global (NYSE: ZETA), the Data-Powered Marketing Cloud, today announced the planned release…
PC Connection, Inc. (CNXN) to Release Fourth Quarter and Full Year Results For 2022
MERRIMACK, N.H.–(BUSINESS WIRE)–Connection (PC Connection, Inc.; NASDAQ: CNXN), a leading information technology solutions provider to…
CorEnergy Announces Tax Characterization of 2022 Distributions
KANSAS CITY, Mo.–(BUSINESS WIRE)–$CORR–CorEnergy Infrastructure Trust, Inc. (NYSE: CORR, CORRPrA) (“CorEnergy” or the “Company”) today…
Ørsted and Eversource Propose New Wind Farm in New York, Building on Record of National Leadership as State Expands Offshore Wind Energy
Developers of South Fork Wind and Sunrise Wind Submit Joint Proposal in New York’s Third…
Equinor and bp Bid for Third New York Offshore Wind Solicitation
Significant New Investments and Innovative Opportunities Envisioned for State NEW YORK–(BUSINESS WIRE)–Equinor and bp today…
BioAegis Therapeutics Announces FDA Clearance of IND for its ‘Inflammation Regulator Protein,’ Gelsolin, for the Treatment of ARDS
NORTH BRUNSWICK, N.J., Jan. 26, 2023 (GLOBE NEWSWIRE) — BioAegis Therapeutics, Inc., a clinical-stage company…
Psycheceutical Bioscience Provisional Patent Application for Novel Ketamine Topical for the Treatment of PTSD
Topical ketamine formulations could improve the methods of treating post-traumatic stress disorder (PTSD) MIAMI, Jan….
NordPass will store passkeys and offer passwordless authentication
LONDON, Jan. 26, 2023 (GLOBE NEWSWIRE) — On Thursday, NordPass, the password management company, announced…
Redfin Reports Pending Home Sales Improve in January As More Buyers Return
Pending sales posted their smallest year-over-year decline in three months as mortgage rates ticked down….
VAH Delivered Its Second New Airbus A220-300 in 2022 and Announces Five More A220 Aircraft Under Sale and Leaseback
STAMFORD, Conn.–(BUSINESS WIRE)–Voyager Aviation Holdings, LLC (“VAH,” the “Company”) announced that the Company has recently…
RealDefense Acquires SUPERAntiSpyware From Support.com
The Fifth in Its Acquisition Spree of Security Technology Companies and Brands PASADENA, Calif.–(BUSINESS WIRE)–#acquisition–RealDefense…
KBRA Releases Research – A Reflection on Bank Earnings: Benefits of Fiscal Stimulus and Fed Monetary Easing
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases a research report examining bank earnings during the past several years,…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Sotera Health Company (SHC) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
Kurt Hediger Joins Graystone Brokerage as Senior Vice President
Kurt Hediger’s arrival bolsters GCA’s industrial capital markets nationwide NEWPORT BEACH, Calif.–(BUSINESS WIRE)–Graystone Capital Advisors,…
Boston Business Journal Names TechTarget a 2023 Middle Market Leader
NEWTON, Mass.–(BUSINESS WIRE)–Global technology media and purchase intent data and services company TechTarget, Inc. (Nasdaq:…
Digital Air Strike Strategically Rebrands to DAS Technology and Acquires 7th Company
Leading Customer Data and Experience Platform (CDXP) company continues enhancing car buying and ownership journey…
Acerus Files For CCAA Protection
TORONTO, Jan. 26, 2023 (GLOBE NEWSWIRE) — Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:…
Centessa Pharmaceuticals Announces FDA Clearance of IND Application for Phase 1/2a Clinical Trial of LB101, First LockBody® Candidate, for Solid Tumors
LB101 is a conditionally tetravalent PD-L1xCD47 LockBody bispecific monoclonal antibody being developed for solid tumors BOSTON…
LAPIX Therapeutics Inc. Announces a Successful Conclusion of its Pre-IND Meeting Request with the U.S. FDA
BOSTON, Jan. 26, 2023 (GLOBE NEWSWIRE) — LAPIX Therapeutics, Inc. (“LAPIX”), a biopharma company focused…